Phio Pharmaceuticals Corp (NASDAQ: PHIO) kicked off on Monday, down -13.74% from the previous trading day, before settling in for the closing price of $1.31. Over the past 52 weeks, PHIO has traded in a range of $0.97-$9.79.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 66.30%. While this was happening, its average annual earnings per share was recorded 82.76%. With a float of $8.61 million, this company’s outstanding shares have now reached $10.76 million.
Phio Pharmaceuticals Corp (PHIO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Phio Pharmaceuticals Corp is 20.06%, while institutional ownership is 1.77%. The most recent insider transaction that took place on Nov 21 ’25, was worth 5,700. In this transaction Chairman, Pres. & CEO of this company bought 5,000 shares at a rate of $1.14, taking the stock ownership to the 281,421 shares. Before that another transaction happened on Nov 18 ’25, when Company’s Chairman, Pres. & CEO bought 5,000 for $1.27, making the entire transaction worth $6,350. This insider now owns 276,421 shares in total.
Phio Pharmaceuticals Corp (PHIO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 82.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 59.13% during the next five years compared to 66.30% growth over the previous five years of trading.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Trading Performance Indicators
Take a look at Phio Pharmaceuticals Corp’s (PHIO) current performance indicators. Last quarter, stock had a quick ratio of 6.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.24, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.00 in one year’s time.
Technical Analysis of Phio Pharmaceuticals Corp (PHIO)
The latest stats from [Phio Pharmaceuticals Corp, PHIO] show that its last 5-days average volume of 0.53 million was inferior to 3.53 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 52.59%.
During the past 100 days, Phio Pharmaceuticals Corp’s (PHIO) raw stochastic average was set at 1.61%, which indicates a significant decrease from 14.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1102 in the past 14 days, which was lower than the 0.1597 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7980, while its 200-day Moving Average is $1.9565. Now, the first resistance to watch is $1.2533. This is followed by the second major resistance level at $1.3767. The third major resistance level sits at $1.4433. If the price goes on to break the first support level at $1.0633, it is likely to go to the next support level at $0.9967. The third support level lies at $0.8733 if the price breaches the second support level.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) Key Stats
The company with the Market Capitalisation of 12.16 million has total of 10,764K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -7,150 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -2,390 K.
